RxDoctor Payments Data

Daniel Kapner, DO

Physical Medicine & Rehabilitation · Freeport, NYNPI 1467870865

Payments from drug & device makers

$2,905in general payments, 2019–2025

Across 154 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$900
  • Scilex Pharmaceuticals Inc.$517
  • Medtronic$397
  • Relievant Medsystems, Inc.$235
  • Redhill Biopharma Inc.$162
  • Averitas Pharma Inc.$142
  • plus $551 from 13 others

What the payments were for

  • Food & beverage$2,905100%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,905 in reported general payments places this provider in the 85th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York

Medicare billing

Part B allowed, 2024
$44,495
Medicare patients
103
Services billed
997

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
QutenzaCapsaicin/Skin Cleanser16$57,892
ZtlidoLidocaine52$30,354
OxycontinOxycodone Hcl24$20,046
LyricaPregabalin17$14,670
Lidocaine110$14,628
Diclofenac Sodium341$8,722
MovantikNaloxegol Oxalate11$4,176
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen90$3,137
Oxycodone Hcl156$2,613
Gabapentin390$1,960
Celecoxib54$1,547
Cyclobenzaprine Hcl163$1,220
Pregabalin43$997
Tramadol Hcl ErTramadol Hcl18$914
Nabumetone88$787

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Ztlido$517$30,35452 claims
PfizerLyrica$76$14,67017 claims
Redhill Biopharma Inc.Movantik$162$4,17611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 872 physical medicine & rehabilitation providers in New York.

Other physical medicine & rehabilitation in Freeport

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →